Dilution was a total game changer on the technicals. The trend lines now are btwn $4.75-$5.70. The main trend it's in is a rising flag pattern with another leg up.(hopefully on news) May want to lighten up in the next run up. Usually the SP falls back and seeing how FDA won't happen till next year, there won't be much to keep investors sitting tight, except for maybe iwhat's in Brandon's Kitty literbox.
For a biotech company, TSRX was in strong cash position, and that secondary offering (which has ended) will make TSRX even more strong. TSRX will gradually increase SP as it reach towards March catalyst.